Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
As of today, Zoetis(ZTS) shares are valued at $122.06. The company's market cap stands at 53.78B, with a P/E ratio of 20.57 and a dividend yield of 1.6%.
During the trading session on 2025-11-23, Zoetis(ZTS) shares reached a daily high of $122.36 and a low of $116.00. At a current price of $122.06, the stock is +5.2% higher than the low and still -0.2% under the high.
Trading volume for Zoetis(ZTS) stock has reached 6.37M, versus its average volume of 4.94M.
Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $181.85 and a low of $115.25.
Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $181.85 and a low of $115.25.
ZTS News
As the animal health industry navigates a rapidly evolving landscape, companies are increasingly challenged to maintain their competitive edge through innovatio...
KeyBanc analyst Steve Dechert initiated coverage of Zoetis (ZTS) with a Sector Weight rating. The firm is citing continued headwinds from the launch of the comp...
KeyBanc initiated coverage of Zoetis (ZTS) with a Sector Weight rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking f...
Analyst ratings
71%
of 21 ratingsMore ZTS News
Stifel analyst Jonathan Block lowered the firm’s price target on Zoetis (ZTS) to $130 from $140 and keeps a Hold rating on the shares. Following Q3 results, the...